Clinical trials
Stress Disorders, Post-Traumatic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 9 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University | 7 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Shaanxi Normal University | 2 |
| Xijing Hospital | 2 |
| Adai Technology (Beijing) Co., Ltd. | 1 |
| Affiliated Hospital of Nantong University | 1 |
| Central South University | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| JianHao Zhang | 1 |
| Karolinska Institutet | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stress Disorders, Post-Traumatic | 26 |
| Anxiety Disorders | 5 |
| COVID-19 | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Adjustment Disorders | 1 |
| Borderline Personality Disorder | 1 |
| Brain Concussion | 1 |
| Cognitive Dysfunction | 1 |
| Combat Disorders | 1 |
| Depressive Disorder | 1 |
Trials
Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.